Cargando…

Synergistic effect of ibrutinib and CD19 CAR‐T cells on Raji cells in vivo and in vitro

Ibrutinib might improve the efficacy of anti‐CD19 chimeric antigen receptor (CD19 CAR) T‐cell therapy in chronic lymphocytic leukemia (CLL). We studied the possibility and mechanism of the synergistic effect of ibrutinib and CAR‐T cells in other types of lymphoma. In this study, we selected the CD19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Meijing, Wang, Xuelin, Li, Zheng, Zhang, Rui, Mu, Juan, Jiang, Yanyu, Deng, Qi, Sun, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648031/ https://www.ncbi.nlm.nih.gov/pubmed/32876369 http://dx.doi.org/10.1111/cas.14638

Ejemplares similares

Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo
por: Ye, Xiupeng, et al.
Publicado: (2022)

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma
por: Liu, Meijing, et al.
Publicado: (2021)

Anti-tumor Efficacy of CD19 CAR-T in a Raji B Cell Xenografted Mouse Model
por: Xiao, Qian, et al.
Publicado: (2023)

Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
por: Zhu, Haibo, et al.
Publicado: (2021)

Effect of Meloxicam on the Proliferation and Apoptosis of the Raji Cell Line: an In Vitro Study
por: Asmarani, Yolanda Kartika, et al.
Publicado: (2022)

CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022)

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia
por: Gill, Saar, et al.
Publicado: (2022)

Shiga Toxin 1, as DNA Repair Inhibitor, Synergistically Potentiates the Activity of the Anticancer Drug, Mafosfamide, on Raji Cells
por: Brigotti, Maurizio, et al.
Publicado: (2013)

CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells
por: Jiang, Shuang, et al.
Publicado: (2016)

Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells
por: Wang, Lei, et al.
Publicado: (2012)

Establishment and Evaluation of an in vitro M Cell Model using C2BBe1 Cells and Raji Cells
por: MASUDA, Kazuya, et al.
Publicado: (2011)

Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
por: Perriello, Vincenzo Maria, et al.
Publicado: (2023)

In vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytes.
por: Ng, W. S., et al.
Publicado: (1977)

Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells
Publicado: (1996)

Macropinocytosis is responsible for the uptake of pathogenic and non-pathogenic mycobacteria by B lymphocytes (Raji cells)
por: García-Pérez, Blanca Estela, et al.
Publicado: (2012)

Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
por: Li, Xin, et al.
Publicado: (2021)

Effect of carboplatin injection on Bcl-2 protein expression and apoptosis induction in Raji cells
por: Lin, Peng, et al.
Publicado: (2020)

Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
por: Yin, Yuzhen, et al.
Publicado: (2022)

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
por: He, Yizi, et al.
Publicado: (2019)

Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells
por: Balhorn, Rod, et al.
Publicado: (2009)

Fisetin targets phosphatidylinositol-3-kinase and induces apoptosis of human B lymphoma Raji cells
por: Lim, Ji Yeon, et al.
Publicado: (2015)

The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
por: Susilowati, Heni, et al.
Publicado: (2019)

CD47 expression is critical for CAR T-cell survival in vivo
por: Beckett, Alex N, et al.
Publicado: (2023)

Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells
por: Xiao, Kai, et al.
Publicado: (2016)

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant
por: Liu, Pengjiang, et al.
Publicado: (2020)

Retracted: Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
por: Luo, Zhiqiang, et al.
Publicado: (2023)

Identification of Significant Pathways Induced by PAX5 Haploinsufficiency Based on Protein-Protein Interaction Networks and Cluster Analysis in Raji Cell Line
por: Gu, Jia, et al.
Publicado: (2017)

A Metabonomic Study of the Effect of Methanol Extract of Ginger on Raji Cells Using (1)HNMR Spectroscopy
por: Parvizzadeh, N., et al.
Publicado: (2014)

Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK
por: Li, Ling, et al.
Publicado: (2023)

Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models
por: Si, Xiaohui, et al.
Publicado: (2022)

Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease
por: Deng, Haobin, et al.
Publicado: (2021)

Efficacy and follow‐up of humanized anti‐BCMA CAR‐T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary‐extraosseous, extramedullary‐bone related, and without extramedullary disease
por: Li, Wei, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
por: Delgado, Julio, et al.
Publicado: (2019)

Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo
por: Wang, Hezhi, et al.
Publicado: (2020)

Histone H4 is cleaved by granzyme A during staurosporine-induced cell death in B-lymphoid Raji cells
por: Lee, Phil Young, et al.
Publicado: (2016)

Effects of complement and serum IgG on rituximab-dependent natural killer cell-mediated cytotoxicity against Raji cells
por: Li, Yang, et al.
Publicado: (2019)

Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation
por: Zheng, Chanli, et al.
Publicado: (2019)

Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk
por: Lyu, Cuicui, et al.
Publicado: (2021)

Low Level Donor Chimerism of CD19 CAR-T Cells Returned to Complete Donor Chimerism in Patients with Relapse After Allo-Hematopoietic Stem Cell Transplant
por: Li, Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uhplc1hf7t59gmdq9glbbg87nl